Journal of Pediatrics最新文献_第8页

Corrigendum to Therapeutic Hypothermia in Low- and Middle-Income Countries: A Systematic Review and Meta-Analysis (J Pediatr. 2025;288:114793. doi:10.1016/j.jpeds.2025.114793) 治疗性低温治疗在低收入和中等收入国家的纠正：系统评价和荟萃分析[J]儿科学，2015;28:114793。doi: 10.1016 / j.jpeds.2025.114793)

IF 3.5 2区医学 Q1 PEDIATRICS

Journal of Pediatrics

Pub Date : 2025-12-12 DOI: 10.1016/j.jpeds.2025.114923

H.C. Lee , D.T. Costa-Nobre , A.C. Katheria , R. Mausling , F.L. Nakwa , G.M. Schmölzer , G.M. Weiner , H.G. Liley , ILCOR NLS Task Force

引用次数: 0

Upholding Our PROMISE: National Survey of Pediatrics Residents’ Experiences with Discrimination, Burnout, Belonging, Professional Fulfillment, and Career Plans 坚持我们的承诺：全国儿科住院医师在歧视、倦怠、归属感、专业成就感和职业规划方面的经历调查。

IF 3.5 2区医学 Q1 PEDIATRICS

Journal of Pediatrics

Pub Date : 2025-12-12 DOI: 10.1016/j.jpeds.2025.114957

Audrea M. Burns PhD , Laura Kester Prakash MD, MPH , Lahia Yemane MD , Oriaku Kas-Osoka MD, MEd , Rebecca Blankenburg MD, MPH , Jyothi Marbin MD, MPH , Patricia Poitevien MD, Msc , Alan Schwartz PhD, JD , Candice Taylor Lucas MD, MPH

Objective

To explore associations between pediatrics residents’ experiences with discrimination, burnout, belonging, professional fulfillment, and career plans, including interest in remaining at their training institution.

Study design

Between October 2020 and January 2021, a national, cross-sectional study titled PROMISE (PROmoting Med-Ed Insight into Supportive Environments) used a 23-item survey of pediatrics residents through the Association of Pediatric Program Directors Longitudinal Educational Assessment Research Network. Descriptive, association, and mediation analyses were conducted for underrepresented in medicine (UIM), Asian and Asian American (AAA), and White residents using multilevel regression and structural equation models.

Results

The study included 799 pediatrics residents (20% UIM) from 24 residency programs. UIM and AAA residents experienced higher discrimination. Among UIM residents, staff discrimination was associated with greater interpersonal disengagement (P = .02), work exhaustion (P < .01), and lower professional fulfillment (P = .04). UIM (P < .01) and AAA (P = .01) residents reported lower belonging even after adjusting for discrimination. Greater belonging was associated with higher likelihood of wanting to remain at one's institution (B = 0.46, 95% CI 0.34-0.57; P < .001). Belonging and professional fulfillment mediated associations between discrimination and intent to stay among UIM residents; for AAA residents, only belonging was a significant mediator.

Conclusions

UIM and AAA pediatric residents reported disproportionately higher discrimination, which was associated with increased burnout and reduced belonging. Institutional efforts to address discrimination are critical for promoting resident well-being and retention in academic medicine.

目的：探讨儿科住院医师歧视经历、职业倦怠、归属感、职业成就感和职业规划（包括留在培训机构的兴趣）之间的关系。研究设计：在2020年10月至2021年1月期间，一项名为PROMISE（促进医学教育对支持环境的洞察）的全国性横断面研究通过儿科项目主任协会纵向教育评估研究网络对儿科居民进行了23项调查。采用多水平回归和结构方程模型对医学（UIM）、亚裔和亚裔美国人（AAA）和白人居民的代表性不足进行了描述性、相关性和中介分析。结果：本研究包括来自24个住院医师项目的799名儿科住院医师（20%为UIM）。UIM和AAA的居民受到的歧视更高。在UIM住院医师中，员工歧视与较高的人际脱离（P = .02）、工作疲惫（P < .01）和较低的职业成就感（P = .04）相关。UIM （P < 0.01）和AAA （P = 0.01）的居民即使在调整歧视后也报告了较低的归属感。更大的归属感与更大的希望留在自己所在机构的可能性相关（B = 0.46, 95% CI 0.34-0.57; P < 0.001）。归属感和职业成就感在大学居民歧视与逗留意向之间的中介作用对于AAA级居民，只有归属感是显著的中介。结论：UIM和AAA儿科住院医师报告了不成比例的高歧视，这与倦怠增加和归属感减少有关。解决歧视问题的机构努力对于促进居民福利和保留学术医学至关重要。

{"title":"Upholding Our PROMISE: National Survey of Pediatrics Residents’ Experiences with Discrimination, Burnout, Belonging, Professional Fulfillment, and Career Plans","authors":"Audrea M. Burns PhD , Laura Kester Prakash MD, MPH , Lahia Yemane MD , Oriaku Kas-Osoka MD, MEd , Rebecca Blankenburg MD, MPH , Jyothi Marbin MD, MPH , Patricia Poitevien MD, Msc , Alan Schwartz PhD, JD , Candice Taylor Lucas MD, MPH","doi":"10.1016/j.jpeds.2025.114957","DOIUrl":"10.1016/j.jpeds.2025.114957","url":null,"abstract":"<div><h3>Objective</h3><div>To explore associations between pediatrics residents’ experiences with discrimination, burnout, belonging, professional fulfillment, and career plans, including interest in remaining at their training institution.</div></div><div><h3>Study design</h3><div>Between October 2020 and January 2021, a national, cross-sectional study titled PROMISE (PROmoting Med-Ed Insight into Supportive Environments) used a 23-item survey of pediatrics residents through the Association of Pediatric Program Directors Longitudinal Educational Assessment Research Network. Descriptive, association, and mediation analyses were conducted for underrepresented in medicine (UIM), Asian and Asian American (AAA), and White residents using multilevel regression and structural equation models.</div></div><div><h3>Results</h3><div>The study included 799 pediatrics residents (20% UIM) from 24 residency programs. UIM and AAA residents experienced higher discrimination. Among UIM residents, staff discrimination was associated with greater interpersonal disengagement (<em>P</em> = .02), work exhaustion (<em>P</em> < .01), and lower professional fulfillment (<em>P</em> = .04). UIM (<em>P</em> < .01) and AAA (<em>P</em> = .01) residents reported lower belonging even after adjusting for discrimination. Greater belonging was associated with higher likelihood of wanting to remain at one's institution (B = 0.46, 95% CI 0.34-0.57; <em>P</em> < .001). Belonging and professional fulfillment mediated associations between discrimination and intent to stay among UIM residents; for AAA residents, only belonging was a significant mediator.</div></div><div><h3>Conclusions</h3><div>UIM and AAA pediatric residents reported disproportionately higher discrimination, which was associated with increased burnout and reduced belonging. Institutional efforts to address discrimination are critical for promoting resident well-being and retention in academic medicine.</div></div>","PeriodicalId":54774,"journal":{"name":"Journal of Pediatrics","volume":"291 ","pages":"Article 114957"},"PeriodicalIF":3.5,"publicationDate":"2025-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145758296","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Assessment of Oral Anticancer Medicines in Pediatric Patients before the Research to Accelerate Cures and Equity (RACE) Act, 2007-2021 2007-2021年RACE法案出台前儿科患者口服抗癌药物的评估

IF 3.5 2区医学 Q1 PEDIATRICS

Journal of Pediatrics

Pub Date : 2025-12-12 DOI: 10.1016/j.jpeds.2025.114949

Mahnum Shahzad PhD , Steven G. DuBois MD , Rebecca Costa MS , Stephanie Argetsinger MS, MPH , Dennis Ross-Degnan ScD , Florence T. Bourgeois MD, MPH , Anita K. Wagner PharmD, MPH, DrPH

Objective

To assess the relationship between availability of pediatric labeling information as well as on-label pediatric safety information and the use of oral targeted anticancer medications (OTAMs) by pediatric patients.

Study design

We identified all OTAMs first approved by the Food and Drug Administration from January 1, 2007, to September 31, 2021, and assessed their use by children with cancers on the basis of claims data in Optum's deidentified Clinformatics Data Mart from January 1, 2007, to September 31, 2021.

Results

Over the study period and across cancer types, 3.8% of patients with childhood cancer received at least 1 OTAM. The majority of OTAMs used (29.4% in 2008 and 51.7% to 88.6% in other years) did not have an indication for the diagnosed pediatric cancers. First OTAM treatment episodes lasted longer (ie, discontinuations happened later) for drugs with pediatric cancer indications and safety information compared with those without the information during the episode of use. From 2007 to 2021, median standard costs of 30-day supplies of OTAMs for patients <18 years old were $6714 and inflation-adjusted, out-of-pocket median spending for a 30-day supply of OTAMs was about $11.

Conclusions

Our results show relatively limited yet increasing pediatric OTAM use over time. We document a greater likelihood of earlier discontinuation and significant financial cost for drugs without on-label pediatric cancer indications and safety information. There is a need for a robust regulatory framework to mandate the timely generation of pediatric population-specific efficacy and safety evidence.

目的：评估儿科标签信息和标签上安全信息的可获得性与儿科患者口服靶向抗癌药物（OTAMs）的使用之间的关系。研究设计：我们确定了2007年1月1日至2021年9月31日期间首次获得美国食品和药物管理局批准的所有OTAMs，并根据Optum的去标识Clinformatics®数据集市（2007年1月1日至2021年9月31日）的索赔数据，评估了癌症儿童对OTAMs的使用情况。结果：在整个研究期间，所有癌症类型中，3.8%的儿童癌症患者至少接受了一次OTAM。大多数使用的otam（2008年为29.4%，其他年份为51.7%至88.6%）没有诊断出儿童癌症的指征。有儿童癌症适应症和安全信息的药物与在使用期间没有相关信息的药物相比，首次OTAM治疗持续时间更长（即停药时间较晚）。结论：我们的研究结果显示，随着时间的推移，儿科OTAM的使用相对有限，但仍在增加。我们记录了没有标签上的儿童癌症适应症和安全信息的药物早期停药的更高可能性和显著的财务成本。有必要建立一个强有力的监管框架，以强制要求及时生成针对儿科人群的有效性和安全性证据。

{"title":"Assessment of Oral Anticancer Medicines in Pediatric Patients before the Research to Accelerate Cures and Equity (RACE) Act, 2007-2021","authors":"Mahnum Shahzad PhD , Steven G. DuBois MD , Rebecca Costa MS , Stephanie Argetsinger MS, MPH , Dennis Ross-Degnan ScD , Florence T. Bourgeois MD, MPH , Anita K. Wagner PharmD, MPH, DrPH","doi":"10.1016/j.jpeds.2025.114949","DOIUrl":"10.1016/j.jpeds.2025.114949","url":null,"abstract":"<div><h3>Objective</h3><div>To assess the relationship between availability of pediatric labeling information as well as on-label pediatric safety information and the use of oral targeted anticancer medications (OTAMs) by pediatric patients.</div></div><div><h3>Study design</h3><div>We identified all OTAMs first approved by the Food and Drug Administration from January 1, 2007, to September 31, 2021, and assessed their use by children with cancers on the basis of claims data in Optum's deidentified Clinformatics Data Mart from January 1, 2007, to September 31, 2021.</div></div><div><h3>Results</h3><div>Over the study period and across cancer types, 3.8% of patients with childhood cancer received at least 1 OTAM. The majority of OTAMs used (29.4% in 2008 and 51.7% to 88.6% in other years) did not have an indication for the diagnosed pediatric cancers. First OTAM treatment episodes lasted longer (ie, discontinuations happened later) for drugs with pediatric cancer indications and safety information compared with those without the information during the episode of use. From 2007 to 2021, median standard costs of 30-day supplies of OTAMs for patients <18 years old were $6714 and inflation-adjusted, out-of-pocket median spending for a 30-day supply of OTAMs was about $11.</div></div><div><h3>Conclusions</h3><div>Our results show relatively limited yet increasing pediatric OTAM use over time. We document a greater likelihood of earlier discontinuation and significant financial cost for drugs without on-label pediatric cancer indications and safety information. There is a need for a robust regulatory framework to mandate the timely generation of pediatric population-specific efficacy and safety evidence.</div></div>","PeriodicalId":54774,"journal":{"name":"Journal of Pediatrics","volume":"290 ","pages":"Article 114949"},"PeriodicalIF":3.5,"publicationDate":"2025-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145758337","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Prevalence of Food Insufficiency Across Subgroups of Children with Special Health-Care Needs 有特殊保健需要的儿童亚群中食物不足的发生率

IF 3.5 2区医学 Q1 PEDIATRICS

Journal of Pediatrics

Pub Date : 2025-12-12 DOI: 10.1016/j.jpeds.2025.114950

Claire E. Branley BS , Anne E. Fuller MD, MS , Jessica Caouette BS , Alon Peltz MD, MBA, MHS , Arvin Garg MD, MPH , Stephenie C. Lemon PhD

Objective

To determine the association between subgroups of children with special health care needs (SHCN) and food insufficiency, and assess whether this association varies by income level, and to evaluate how food insufficiency trends have changed over the time.

Study design

This was a cross-sectional survey study using the 2016-2023 National Surveys of Children's Health. SHCN subgroups were defined as follows: no special health care needs, prescription medication use only, elevated use of services, and functional limitations. The association between SHCN subgroup and food insufficiency was measured using weighted multivariable logistic regression models. Effect modification by income was evaluated. In addition, linear models described significant changes in food insufficiency rates by SHCN subgroup from 2016 to 2023.

Results

Compared with children without SHCN, children with SHCN who used medications only (aOR = 1.31; 95% CI 1.21-1.41), had elevated use of services (aOR = 1.54; 95% CI 1.45-1.63), or had functional limitations (aOR 1.97; 95% CI 1.82-2.13) had higher odds of food insufficiency. Effect modification by income was significant for children with functional limitations. From 2016 to 2023, the associations between SHCN and food insufficiency were similar.

Conclusion

Children with functional limitations are an especially high-risk group who require attention in public health efforts to reduce food insufficiency.

目的：确定有特殊保健需要的儿童亚群（SHCN）与食物不足之间的关系，并评估这种关系是否因收入水平而异，以及食物不足趋势如何随时间变化。研究设计：这是一项使用2016-2023年全国儿童健康调查的横断面调查研究。SHCN亚组的定义如下：无特殊医疗需求、仅使用处方药、服务使用率较高和功能受限。使用加权多变量logistic回归模型测量SHCN亚组与食物不足之间的关联。评价了收入对效果的影响。此外，线性模型描述了2016-2023年SHCN亚组食物不足率的显著变化。结果：与没有SHCN的儿童相比，仅使用药物的SHCN儿童（aOR=1.31; 95% CI 1.21-1.41），服务使用增加（aOR=1.54; 95% CI 1.45-1.63），或有功能限制（aOR 1.97; 95% CI 1.82-2.13），食物不足的几率更高。贫困对功能障碍儿童的影响显著。从2016年到2023年，SHCN与食物不足之间的关联相似。结论：功能障碍儿童是一个特别的高危人群，需要在公共卫生工作中予以重视，以减少食物不足。

{"title":"Prevalence of Food Insufficiency Across Subgroups of Children with Special Health-Care Needs","authors":"Claire E. Branley BS , Anne E. Fuller MD, MS , Jessica Caouette BS , Alon Peltz MD, MBA, MHS , Arvin Garg MD, MPH , Stephenie C. Lemon PhD","doi":"10.1016/j.jpeds.2025.114950","DOIUrl":"10.1016/j.jpeds.2025.114950","url":null,"abstract":"<div><h3>Objective</h3><div>To determine the association between subgroups of children with special health care needs (SHCN) and food insufficiency, and assess whether this association varies by income level, and to evaluate how food insufficiency trends have changed over the time.</div></div><div><h3>Study design</h3><div>This was a cross-sectional survey study using the 2016-2023 National Surveys of Children's Health. SHCN subgroups were defined as follows: no special health care needs, prescription medication use only, elevated use of services, and functional limitations. The association between SHCN subgroup and food insufficiency was measured using weighted multivariable logistic regression models. Effect modification by income was evaluated. In addition, linear models described significant changes in food insufficiency rates by SHCN subgroup from 2016 to 2023.</div></div><div><h3>Results</h3><div>Compared with children without SHCN, children with SHCN who used medications only (aOR = 1.31; 95% CI 1.21-1.41), had elevated use of services (aOR = 1.54; 95% CI 1.45-1.63), or had functional limitations (aOR 1.97; 95% CI 1.82-2.13) had higher odds of food insufficiency. Effect modification by income was significant for children with functional limitations. From 2016 to 2023, the associations between SHCN and food insufficiency were similar.</div></div><div><h3>Conclusion</h3><div>Children with functional limitations are an especially high-risk group who require attention in public health efforts to reduce food insufficiency.</div></div>","PeriodicalId":54774,"journal":{"name":"Journal of Pediatrics","volume":"290 ","pages":"Article 114950"},"PeriodicalIF":3.5,"publicationDate":"2025-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145758364","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Children with Medical Complexity and Their Families: Addressing Social Risks and Advancing Integrated Care Models 儿童与医疗复杂性及其家庭：解决社会风险和推进综合护理模式。

IF 3.5 2区医学 Q1 PEDIATRICS

Journal of Pediatrics

Pub Date : 2025-12-11 DOI: 10.1016/j.jpeds.2025.114951

Maria Pastore MD , Tudor Lucian Pop MD , Esra Sevketoglu MD , Donjeta Bali MD , Ida Giardino MD , Mehmet Vural MD , Massimo Pettoello-Mantovani MD, PhD

引用次数: 0

Intranasal Septal Hematoma: A Diagnosis Not to Miss 鼻中隔血肿：一个不容错过的诊断。

IF 3.5 2区医学 Q1 PEDIATRICS

Journal of Pediatrics

Pub Date : 2025-12-11 DOI: 10.1016/j.jpeds.2025.114947

Joana De Beir MD, Diana Valbom Gonçalves MD, Joana Miguéis MD, José Romão MD

引用次数: 0

Maternal-Fetal Environment and Neurodevelopment in Patients with Single Ventricle Heart Disease 单心室心脏病患者的母胎环境与神经发育。

IF 3.5 2区医学 Q1 PEDIATRICS

Journal of Pediatrics

Pub Date : 2025-12-11 DOI: 10.1016/j.jpeds.2025.114942

Samantha A. Holmes MD , Krista Young MD , Kelly R. Wolfe PhD , Camila Londono-Obregon MD , Bettina F. Cuneo MD , Emily M. Bucholz MD, PhD, MPH

Objective

To assess the role of the maternal-fetal environment (MFE) on early neurodevelopmental and clinical outcomes in children with single ventricle heart disease (SVHD).

Study design

We performed a retrospective, single-center study of patients with a prenatal diagnosis of SVHD from 2011-2022. Impaired MFE was defined as exposure to diabetes, pre-eclampsia, tobacco, or chronic or gestational hypertension in utero. Neurodevelopmental outcomes were assessed using the Bayley Scales of Infant and Toddler Development-III and 4 between 12 and 36 months of age.

Results

Among 160 patients with SVHD (117 hypoplastic left heart and 43 hypoplastic right heart), 78 completed neurodevelopmental testing. Exposure to an impaired MFE was associated with lower cognitive scores (P = .030), although this association became nonsignificant after adjustment for clinical covariates. Impaired MFE was also associated with lower language and receptive communication scores after clinical adjustment (P = .023 and P = .040, respectively) but became nonsignificant after further adjustment for the Child Opportunity Index. No significant differences were observed in fine or gross motor scores, neonatal complications, hospital or intensive care unit stay, and 1-year mortality or transplantation between groups.

Conclusions

Among patients with SVHD, exposure to an impaired MFE was associated with lower cognitive and language outcomes, although these associations were attenuated after accounting for clinical and socioeconomic factors. These findings highlight the importance of early identification and monitoring of children with adverse prenatal exposures.

目的：探讨母胎环境（MFE）对单心室心脏病（SVHD）患儿早期神经发育及临床预后的影响。研究设计：我们对2011-2022年产前诊断为SVHD的患者进行了一项回顾性单中心研究。MFE受损定义为子宫内暴露于糖尿病、先兆子痫、烟草或慢性或妊娠期高血压。在12-36个月龄之间使用Bayley婴幼儿发育量表iii和4来评估神经发育结果。结果：160例SVHD患者（左心发育不全117例，右心发育不全43例）中，78例完成了神经发育测试。暴露于受损的MFE与较低的认知评分相关（P=0.030），尽管在调整临床协变量后，这种关联变得不显著。临床调整后，MFE受损也与较低的语言和接受性沟通得分相关（P分别=0.023和P=0.040），但在进一步调整儿童机会指数后，这一差异不显著。在精细或大运动评分、新生儿并发症、住院或重症监护病房时间、1年死亡率或移植方面，组间无显著差异。结论：在SVHD患者中，暴露于受损的MFE与较低的认知和语言结果相关，尽管在考虑了临床和社会经济因素后，这些关联减弱了。这些发现强调了早期识别和监测产前不良暴露儿童的重要性。

{"title":"Maternal-Fetal Environment and Neurodevelopment in Patients with Single Ventricle Heart Disease","authors":"Samantha A. Holmes MD , Krista Young MD , Kelly R. Wolfe PhD , Camila Londono-Obregon MD , Bettina F. Cuneo MD , Emily M. Bucholz MD, PhD, MPH","doi":"10.1016/j.jpeds.2025.114942","DOIUrl":"10.1016/j.jpeds.2025.114942","url":null,"abstract":"<div><h3>Objective</h3><div>To assess the role of the maternal-fetal environment (MFE) on early neurodevelopmental and clinical outcomes in children with single ventricle heart disease (SVHD).</div></div><div><h3>Study design</h3><div>We performed a retrospective, single-center study of patients with a prenatal diagnosis of SVHD from 2011-2022. Impaired MFE was defined as exposure to diabetes, pre-eclampsia, tobacco, or chronic or gestational hypertension in utero. Neurodevelopmental outcomes were assessed using the Bayley Scales of Infant and Toddler Development-III and 4 between 12 and 36 months of age.</div></div><div><h3>Results</h3><div>Among 160 patients with SVHD (117 hypoplastic left heart and 43 hypoplastic right heart), 78 completed neurodevelopmental testing. Exposure to an impaired MFE was associated with lower cognitive scores (<em>P</em> = .030), although this association became nonsignificant after adjustment for clinical covariates. Impaired MFE was also associated with lower language and receptive communication scores after clinical adjustment (<em>P</em> = .023 and <em>P</em> = .040, respectively) but became nonsignificant after further adjustment for the Child Opportunity Index. No significant differences were observed in fine or gross motor scores, neonatal complications, hospital or intensive care unit stay, and 1-year mortality or transplantation between groups.</div></div><div><h3>Conclusions</h3><div>Among patients with SVHD, exposure to an impaired MFE was associated with lower cognitive and language outcomes, although these associations were attenuated after accounting for clinical and socioeconomic factors. These findings highlight the importance of early identification and monitoring of children with adverse prenatal exposures.</div></div>","PeriodicalId":54774,"journal":{"name":"Journal of Pediatrics","volume":"290 ","pages":"Article 114942"},"PeriodicalIF":3.5,"publicationDate":"2025-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145752437","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Healthcare Decision-Making and Evolving Autonomy in Adolescents and Young Adults with Cerebral Palsy 青少年和青年脑瘫患者的医疗决策和自主性发展。

IF 3.5 2区医学 Q1 PEDIATRICS

Journal of Pediatrics

Pub Date : 2025-12-11 DOI: 10.1016/j.jpeds.2025.114953

Chelsey B. Anderson CPO, PhD , Michelle Gorecki MD, MPH , Amy Bailes PT, PhD , Jilda Vargus-Adams MD, MSc , Ellen A. Lipstein MD, MPH

Objective

To evaluate how adolescents and young adults with cerebral palsy (AYACP) make mobility-related health care decisions and seek their perspectives on making decisions about mobility-related health care interventions.

Study design

We purposively recruited AYACP ages 13-21 years from an academic medical center to participate in qualitative semistructured individual interviews. Interview questions explored mobility-related health care interventions and decision-making. We recorded, transcribed, coded, and analyzed interviews using thematic analysis.

Results

AYACP described multiple mobility-related health care decisions and cycling between testing out and choosing interventions. The research team identified four themes: balancing autonomy and support; connecting evolving knowledge and goals to intervention outcomes motivates decision participation; limited agency; and desire for options that effectively address AYACPs’ individual needs. AYACPs want to participate in decision-making about interventions to address their mobility-related goals but describe needing support from adults. AYACP also described their knowledge and goals as evolving throughout adolescence, which often motivated their participation in decisions and treatment plans. In contrast, some AYACP lacked agency in decision-making, which negatively influenced their participation. AYACP have a wide range of individual needs and struggle with finding mobility-related health care interventions that optimally address their individual needs.

Conclusions

AYACP need support in developing knowledge and decision-making skills about mobility-related health care interventions that address their goals. AYACP would benefit from decision support to develop skills for transitioning to adult health care and engaging in decision making.

目的：评价青少年和青壮年脑瘫患者（AYACP）如何做出与活动相关的医疗保健决策，并寻求他们对与活动相关的医疗保健干预决策的看法。研究设计：我们有目的地从一家学术医疗中心招募13-21岁的AYACP参加定性半结构化的个人访谈。访谈问题探讨了与流动性相关的医疗干预和决策。我们使用主题分析对访谈进行记录、转录、编码和分析。结果：AYACP描述了多种与流动性相关的医疗保健决策，以及在测试和选择干预措施之间的循环。研究团队确定了四个主题：平衡自主权和支持；将不断发展的知识和目标与干预结果联系起来，激励决策参与；有限的机构;以及对有效解决ayacp个人需求的选择的渴望。ayacp希望参与有关干预措施的决策，以解决他们与行动相关的目标，但表示需要成年人的支持。AYACP还描述了他们的知识和目标在整个青春期不断发展，这往往促使他们参与决策和治疗计划。相反，部分青年会在决策方面缺乏能动性，这对他们的参与产生了负面影响。AYACP有广泛的个人需求，并努力寻找与流动性相关的医疗干预措施，以最佳地满足他们的个人需求。结论：AYACP需要在发展知识和决策技能方面得到支持，这些知识和决策技能与实现其目标的流动性相关的医疗干预有关。AYACP将受益于决策支持，以发展向成人保健过渡和参与决策的技能。

{"title":"Healthcare Decision-Making and Evolving Autonomy in Adolescents and Young Adults with Cerebral Palsy","authors":"Chelsey B. Anderson CPO, PhD , Michelle Gorecki MD, MPH , Amy Bailes PT, PhD , Jilda Vargus-Adams MD, MSc , Ellen A. Lipstein MD, MPH","doi":"10.1016/j.jpeds.2025.114953","DOIUrl":"10.1016/j.jpeds.2025.114953","url":null,"abstract":"<div><h3>Objective</h3><div>To evaluate how adolescents and young adults with cerebral palsy (AYACP) make mobility-related health care decisions and seek their perspectives on making decisions about mobility-related health care interventions.</div></div><div><h3>Study design</h3><div>We purposively recruited AYACP ages 13-21 years from an academic medical center to participate in qualitative semistructured individual interviews. Interview questions explored mobility-related health care interventions and decision-making. We recorded, transcribed, coded, and analyzed interviews using thematic analysis.</div></div><div><h3>Results</h3><div>AYACP described multiple mobility-related health care decisions and cycling between testing out and choosing interventions. The research team identified four themes: balancing autonomy and support; connecting evolving knowledge and goals to intervention outcomes motivates decision participation; limited agency; and desire for options that effectively address AYACPs’ individual needs. AYACPs want to participate in decision-making about interventions to address their mobility-related goals but describe needing support from adults. AYACP also described their knowledge and goals as evolving throughout adolescence, which often motivated their participation in decisions and treatment plans. In contrast, some AYACP lacked agency in decision-making, which negatively influenced their participation. AYACP have a wide range of individual needs and struggle with finding mobility-related health care interventions that optimally address their individual needs.</div></div><div><h3>Conclusions</h3><div>AYACP need support in developing knowledge and decision-making skills about mobility-related health care interventions that address their goals. AYACP would benefit from decision support to develop skills for transitioning to adult health care and engaging in decision making.</div></div>","PeriodicalId":54774,"journal":{"name":"Journal of Pediatrics","volume":"291 ","pages":"Article 114953"},"PeriodicalIF":3.5,"publicationDate":"2025-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145752455","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Failure to Wean: Predictors and Adverse Outcomes Associated with Pediatric Postextubation Noninvasive Respiratory Support 断奶失败：与儿科拔管后无创呼吸支持相关的预测因素和不良后果。

IF 3.5 2区医学 Q1 PEDIATRICS

Journal of Pediatrics

Pub Date : 2025-12-10 DOI: 10.1016/j.jpeds.2025.114939

Samer Abu-Sultaneh MD, FAAP, FCCM , Colin M. Rogerson MD, MPH , Jeremy M. Loberger MD

Objectives

To describe postextubation noninvasive respiratory support (NRS) use, and its variation based on clinical variables and institution, to identify factors associated with failure to liberate from NRS ≤ 48 hours postextubation, and to explore the association between postextubation NRS use and patient-centered outcomes.

Study design

A retrospective cohort study of patients aged ≤ 18 years exposed to invasive mechanical ventilation (IMV) via endotracheal tube for ≥ 24 hours between January 1, 2013 and December 31, 2022, in the Virtual Pediatric Systems multicenter quality improvement database. Failure to liberate from NRS ≤ 48 hours postextubation was the primary outcome. Mixed-effects logistic regression models were developed for patient-centered outcomes.

Results

A total of 132,712 encounters from 158 institutions were included. High-flow nasal cannula was the most common NRS modality followed by bilevel positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) with rescue deployment more common than planned. Older age, later study year, high-risk primary diagnostic category, use of BiPAP or CPAP, and IMV duration ≥ 7 days were associated with higher odds of failure to liberate from NRS ≤ 48 hours. Patients who failed to be liberated from NRS ≤ 48 hours postextubation had longer NRS duration, longer intensive care unit and hospital lengths of stay, and higher pediatric intensive care unit all-cause mortality. Younger age, high-risk primary diagnostic category, use of rescue CPAP, use of planned as well as rescue BiPAP, and IMV duration ≥ 7 days were associated with higher odds of extubation failure ≤ 48 hours and 7 days.

Conclusions

Postextubation NRS use is highly prevalent and most commonly deployed as a rescue strategy. Failure to liberate from NRS ≤ 48 hours postextubation is associated with worse patient-centered outcomes. Optimizing the postextubation NRS deployment and titration is an important gap in need of research and quality improvement interventions which may lead to improved patients’ outcomes.

目的：描述拔管后无创呼吸支持（NRS）的使用及其基于临床变量和机构的变化，确定拔管后≤48小时未能摆脱NRS的相关因素，并探讨拔管后NRS使用与以患者为中心的结局之间的关系。研究设计：在2013年1月1日至2022年12月31日期间，在Virtual Pediatric Systems多中心质量改善数据库中，对≤18岁的患者进行回顾性队列研究，这些患者通过气管插管接受有创机械通气(IMV)≥24小时。拔管后≤48小时未从NRS中解脱是主要结局。为以患者为中心的结果建立了混合效应logistic回归模型。结果：共纳入来自158个机构的132,712次就诊。高流量鼻插管（HFNC）是最常见的NRS方式，其次是双水平气道正压（BiPAP）和持续气道正压（CPAP），救援部署比计划更常见。年龄较大、研究年份较晚、高危初级诊断类别、BiPAP或CPAP的使用以及IMV持续时间≥7天与NRS≤48小时未能解放的较高几率相关。拔管后≤48小时未能摆脱NRS的患者NRS持续时间更长，重症监护病房（ICU）和住院时间（LOS）更长，儿科ICU全因死亡率更高。年龄较小、高危主要诊断类别、使用抢救性CPAP、使用计划性和抢救性BiPAP、IMV持续时间≥7天与拔管失败的较高几率相关（≤48小时和7天）。结论：拔管后NRS的使用非常普遍，最常作为一种抢救策略。拔管后≤48小时未能摆脱NRS与较差的以患者为中心的结局相关。优化拔管后NRS的部署和滴定是研究和质量改善干预措施的重要空白，可能会改善患者的预后。

{"title":"Failure to Wean: Predictors and Adverse Outcomes Associated with Pediatric Postextubation Noninvasive Respiratory Support","authors":"Samer Abu-Sultaneh MD, FAAP, FCCM , Colin M. Rogerson MD, MPH , Jeremy M. Loberger MD","doi":"10.1016/j.jpeds.2025.114939","DOIUrl":"10.1016/j.jpeds.2025.114939","url":null,"abstract":"<div><h3>Objectives</h3><div>To describe postextubation noninvasive respiratory support (NRS) use, and its variation based on clinical variables and institution, to identify factors associated with failure to liberate from NRS ≤ 48 hours postextubation, and to explore the association between postextubation NRS use and patient-centered outcomes.</div></div><div><h3>Study design</h3><div>A retrospective cohort study of patients aged ≤ 18 years exposed to invasive mechanical ventilation (IMV) via endotracheal tube for ≥ 24 hours between January 1, 2013 and December 31, 2022, in the Virtual Pediatric Systems multicenter quality improvement database. Failure to liberate from NRS ≤ 48 hours postextubation was the primary outcome. Mixed-effects logistic regression models were developed for patient-centered outcomes.</div></div><div><h3>Results</h3><div>A total of 132,712 encounters from 158 institutions were included. High-flow nasal cannula was the most common NRS modality followed by bilevel positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) with rescue deployment more common than planned. Older age, later study year, high-risk primary diagnostic category, use of BiPAP or CPAP, and IMV duration ≥ 7 days were associated with higher odds of failure to liberate from NRS ≤ 48 hours. Patients who failed to be liberated from NRS ≤ 48 hours postextubation had longer NRS duration, longer intensive care unit and hospital lengths of stay, and higher pediatric intensive care unit all-cause mortality. Younger age, high-risk primary diagnostic category, use of rescue CPAP, use of planned as well as rescue BiPAP, and IMV duration ≥ 7 days were associated with higher odds of extubation failure ≤ 48 hours and 7 days.</div></div><div><h3>Conclusions</h3><div>Postextubation NRS use is highly prevalent and most commonly deployed as a rescue strategy. Failure to liberate from NRS ≤ 48 hours postextubation is associated with worse patient-centered outcomes. Optimizing the postextubation NRS deployment and titration is an important gap in need of research and quality improvement interventions which may lead to improved patients’ outcomes.</div></div>","PeriodicalId":54774,"journal":{"name":"Journal of Pediatrics","volume":"290 ","pages":"Article 114939"},"PeriodicalIF":3.5,"publicationDate":"2025-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145745828","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Risk of Celiac Disease Before and After Nationwide Infant Rotavirus Vaccination: A Population-Based Study 全国婴儿轮状病毒疫苗接种前后乳糜泻的风险：一项基于人群的研究

IF 3.5 2区医学 Q1 PEDIATRICS

Journal of Pediatrics

Pub Date : 2025-12-10 DOI: 10.1016/j.jpeds.2025.114938

Maria Östman , Lars C. Stene PhD , German Tapia PhD , Laura Kivelä MD, PhD , Kalle Kurppa MD, PhD , Ketil Størdal MD, PhD , The Human Exposomic Determinants of Immune Mediated Diseases (HEDIMED) Investigator Group

Objective

To study the association between rotavirus vaccination and risk of celiac disease, which remains debated.

Study design

We conducted a nationwide register-based study including 740 744 children born during 2007-2019 from the Norwegian Birth Registry individually linked to the Norwegian Patient Registry for celiac disease diagnosis. With follow-up until 5 years of age, 2795 were diagnosed with celiac disease. The main analysis was an interrupted time series analysis to assess break in trend of celiac disease incidence before compared with after vaccine introduction in September 2014. Furthermore, we linked the cohort to the Norwegian Immunization Register and compared the risk of celiac disease between fully vaccinated and nonvaccinated children. In sensitivity analyses, we excluded children born 1 year before to 1 year after vaccine introduction to mitigate the effect of herd immunity.

Results

There was no significant break in trend after rotavirus vaccine introduction (P = .46). Hazard ratio (HR) of celiac disease was 0.96 (95% CI 0.89-1.04) if born after compared with before vaccination started, and 1.00 (95% CI 0.92-1.09) when excluding children born in 2013-2015. In fully vaccinated compared with nonvaccinated the HR was 0.99 (95% CI 0.92-1.07), consistent in robustness analyses. Including a requirement for gluten-free diet support in the celiac disease case definition gave similar results (HR 1.06, 95% CI 0.98-1.15).

Conclusions

This study did not find an association between rotavirus vaccine and the risk of early-onset celiac disease.

目的：研究轮状病毒疫苗接种与乳糜泻风险之间的关系，这一点仍有争议。研究设计：我们进行了一项全国性的基于登记的研究，包括2007-2019年出生的740,744名儿童，这些儿童来自挪威出生登记处，与挪威患者登记处的乳糜泻诊断相关联。随访至5岁2,795人被诊断为乳糜泻。主要分析是中断时间序列分析，以评估2014年9月引入疫苗前与引入疫苗后乳糜泻发病率趋势的中断。此外，我们将队列与挪威免疫登记联系起来，比较了完全接种疫苗和未接种疫苗的儿童患乳糜泻的风险。在敏感性分析中，我们排除了接种疫苗前1年至接种疫苗后1年出生的儿童，以减轻群体免疫的影响。结果：轮状病毒疫苗接种后，该趋势无明显中断（P=0.46）。与接种疫苗前相比，接种疫苗后出生的乳糜泻风险比（HR）为0.96 (95% CI 0.89-1.04)，排除2013-2015年出生的儿童时为1.00 （95% CI 0.92-1.09）。与未接种疫苗相比，完全接种疫苗的风险比为0.99 (95% CI 0.92-1.07)，与鲁棒性分析一致。在乳糜泻病例定义中包括对无谷蛋白饮食支持的要求也得到了类似的结果（HR 1.06, 95% C: 0.98-1.15）。结论：本研究未发现轮状病毒疫苗与早发性乳糜泻风险之间的关联。

{"title":"Risk of Celiac Disease Before and After Nationwide Infant Rotavirus Vaccination: A Population-Based Study","authors":"Maria Östman , Lars C. Stene PhD , German Tapia PhD , Laura Kivelä MD, PhD , Kalle Kurppa MD, PhD , Ketil Størdal MD, PhD , The Human Exposomic Determinants of Immune Mediated Diseases (HEDIMED) Investigator Group","doi":"10.1016/j.jpeds.2025.114938","DOIUrl":"10.1016/j.jpeds.2025.114938","url":null,"abstract":"<div><h3>Objective</h3><div>To study the association between rotavirus vaccination and risk of celiac disease, which remains debated.</div></div><div><h3>Study design</h3><div>We conducted a nationwide register-based study including 740 744 children born during 2007-2019 from the Norwegian Birth Registry individually linked to the Norwegian Patient Registry for celiac disease diagnosis. With follow-up until 5 years of age, 2795 were diagnosed with celiac disease. The main analysis was an interrupted time series analysis to assess break in trend of celiac disease incidence before compared with after vaccine introduction in September 2014. Furthermore, we linked the cohort to the Norwegian Immunization Register and compared the risk of celiac disease between fully vaccinated and nonvaccinated children. In sensitivity analyses, we excluded children born 1 year before to 1 year after vaccine introduction to mitigate the effect of herd immunity.</div></div><div><h3>Results</h3><div>There was no significant break in trend after rotavirus vaccine introduction (<em>P</em> = .46). Hazard ratio (HR) of celiac disease was 0.96 (95% CI 0.89-1.04) if born after compared with before vaccination started, and 1.00 (95% CI 0.92-1.09) when excluding children born in 2013-2015. In fully vaccinated compared with nonvaccinated the HR was 0.99 (95% CI 0.92-1.07), consistent in robustness analyses. Including a requirement for gluten-free diet support in the celiac disease case definition gave similar results (HR 1.06, 95% CI 0.98-1.15).</div></div><div><h3>Conclusions</h3><div>This study did not find an association between rotavirus vaccine and the risk of early-onset celiac disease.</div></div>","PeriodicalId":54774,"journal":{"name":"Journal of Pediatrics","volume":"290 ","pages":"Article 114938"},"PeriodicalIF":3.5,"publicationDate":"2025-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145745770","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0